MODERATOR
:
SPEAKER
(S):
Dr. Joseph Fratantoni, MD, Senior Clinical Consultant, Biologics Consulting Group
Closed Systems: An Overview
Herb Cullis, President, American Fluoroseal Corporation
How Apheresis Went to a Closed System,,,
James Talmadge, PhD, Professor of Path & Microbiol, Univ of Nebraska, University of Nebraska Medical Center
Designing a Closed System for a Cell Therapeutic
Jeffrey Miripol, Chief Operating Officer, American Fluoroseal
Closed Systems: Sterile Welder Devices
Description
The development of flexible blood containers in the 1950s enabled collection of blood into containers that were integrally connected. This first iteration of closed systems resulted in marked decrease in danger of contamination of transfusion products. Subsequent developments in these systems included special engineering of cell separators and a sterile connection device also known as a "tubing welder." As transfusion and cell therapy development progressed, so did the approach to closed systems and, in addition to systems that were geometrically closed, there were those known as "functionally closed systems." This progression brought with it confusion related to the scientific and regulatory aspects of closed systems. This session will include a brief historical overview of the subject, perspectives on development of products from scientists in industrial and academic organizations and comments on regulatory aspects.
-
Describe how closed systems contribute to safety of transfusion and cell therapy products.
-
Discuss how systems can be developed or modified so that they qualify as "Closed Systems."
-
Review definitions of various types of closed systems.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.